Trocars Market – Enabling Minimally Invasive Surgery with Precision Access Devices

The trocars market is a critical segment of the surgical instruments industry, providing essential access devices for minimally invasive procedures such as laparoscopy, thoracoscopy, and arthroscopy. Trocars are used to create ports through which surgical instruments and cameras can be inserted into the body, enabling surgeons to perform complex procedures with minimal trauma, reduced recovery times, and improved patient outcomes.

The market was valued at USD 0.56 billion in 2024, about USD 0.61 billion in 2025, and is projected to reach roughly USD 1.46 billion by 2035, growing at a CAGR of approximately 9.09%. Growth is driven by the rising prevalence of chronic diseases requiring surgical intervention, increasing adoption of minimally invasive surgeries, technological advancements in trocar design (including safety features and ergonomic improvements), and the growing aging population susceptible to surgical conditions.

By application, laparoscopic surgeries hold the largest share, reflecting their widespread use in general surgery, gynecology, and urology. Robotic surgeries are the fastest-growing segment, driven by the increasing adoption of robotic-assisted platforms like the da Vinci system, which require specialized trocars for instrument access. Other applications include thoracic, orthopedic, and bariatric surgeries, each with specific trocar requirements.

Product type segmentation shows disposable trocars leading due to their convenience, sterility assurance, and reduced risk of cross-contamination. Reusable trocars remain relevant in cost-sensitive settings and specific procedures where durability is prioritized. Safety trocars, featuring mechanisms to prevent organ injury during insertion, are gaining traction due to enhanced patient safety and regulatory support.

End users are led by hospitals, which handle the majority of surgical procedures, followed by ambulatory surgical centers (ASCs) and specialty clinics. ASCs are emerging as a key growth area, driven by the shift toward outpatient care and cost-effective surgical solutions.

Regionally, North America dominates with a valuation of USD 0.25 billion in 2024, projected to reach USD 0.65 billion by 2035, driven by advanced healthcare infrastructure, high adoption of minimally invasive techniques, and strong reimbursement frameworks. Europe follows with steady expansion, while Asia-Pacific is emerging rapidly, fueled by rising healthcare expenditures, increasing surgical volumes, and growing medical tourism.

Key players include Conmed, Zimmer Biomet, Smith and Nephew, Hollister, Intuitive Surgical, Johnson and Johnson, Nippon Surgical Instrument, Stryker, Tryton Medical, KARL STORZ, B. Braun, Medtronic, Olympus Corporation, and Boston Scientific. Strategies focus on developing innovative trocar designs, integrating safety features, and forming partnerships to broaden market reach and enhance product offerings.

Read more: Trocars Market Size, Trends, Demands, Growth Outlook 2035

People Also Ask

Q1. What are trocars used for in surgery?
Trocars are used to create access ports for minimally invasive surgeries, allowing insertion of surgical instruments and cameras into the body cavity for procedures like laparoscopy, thoracoscopy, and robotic-assisted surgeries.

Q2. Which region leads the trocars market?
North America leads due to advanced healthcare infrastructure and high adoption of minimally invasive techniques, while Asia-Pacific is emerging rapidly, driven by rising healthcare expenditures and increasing surgical volumes.

Tags: trocars, minimally invasive surgery, laparoscopic surgery, surgical instruments, robotic surgery, medical devices